Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: A randomised trial

European Journal of Contraception and Reproductive Health Care

Volumn 14, Issue 1, 2009, Pages 55-60

  Caliskan, Eray ^a   Doger, Emek ^a   Cakiroglu, Yigit ^a   Corakci, Aydin ^a   Yucesoy, Izzet ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Induced abortion; Misoprostol; Second trimester abortion; Sublingual

Indexed keywords

MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, SUBLINGUAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 60849096097     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180802360865     Document Type: Article

References (19)

1. Senior J, Marshall K, Sangha R, et al. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 1993;108:501-6.
2. Carbonell JLL, Velazco A, Rodriguez Y, et al. Oral versus vaginal misoprostol for cervical priming in first trimester abortion: a randomized trial. Eur J Contracept Reprod Health Care 2001;6:134-40.
3. Dilbaz S, Caliskan E, Dilbaz B, et al. Frequent low-dose misoprostol for termination of second-trimester pregnancy. Eur J Contracept Reprod Health Care 2004;9:11-5.
4. Caliskan E, Bodur H, Ozeren S, et al. Misoprostol 50 μg sublingually versus vaginally for labor induction at term: a randomized study. Gynecol Obstet Invest 2005;59:155-61.
5. Caliskan E, Dilbaz B, Meydanli MM, et al. Oral misoprostol for the third stage of labor: A randomized controlled trial. Obstet Gynecol 2003;101:921-8.
6. Has R, Batukan C, Ermis H, et al. Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecol Obstet Invest 2002;53:16-21.
7. Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
8. Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:322-6.
9. Marcisz C, Jonderko G, Gina R, et al. Effect of misoprostol, a synthetic equivalent of prostaglandin E1, on bronchodilation in bronchial spasm. Polski Tygodynk Lekarski 1992;47:733-4.
10. Tang OS, Chan CCW, Kan ASY, et al. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Reprod 2005;20:3062-6.
11. Hamoda H, Ashok PW, Flett GMM, et al. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. Hum Reprod 2005;20:2348-54.
12. Bhattacharjee N, Saha SP, Ghoshroy SC, et al. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks. Aust NZ J Obstet Gynaecol 2008;48:165-71.
13. Carbonell JL, Torres MA, Reyes R, et al. Second-trimester pregnancy termination with 600- μg vs. 400-μg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial. Contraception 2008;77:50-5.
14. Dodd JM, Crowther CA. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: A systematic review. Eur J Obstet Gynecol Reprod Biol 2006;125:3-8.
15. Carbonell JL, Valera L, Velazco A, et al. Vaginal misoprostol for early second-trimester abortion. Eur J Contracept Reprod Health Care 1998;3:93-8.
16. Wong KS, Ngai CSW, Yeo ELK, et al. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: A randomized comparative trial. Hum Reprod 2000;15:709-12.
17. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second trimester termination for fetal abnormality. Obstet Gynecol 2003;101:1294-9.
18. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001;64:315-7.
19. Vimala N, Dadhwal V, Mittal S. Sublingual misoprostol for second-trimester abortion. Int J Gynecol Obstet 2004;84:89-90.